Daily non-political popular news in brief.

Surgical biopsy may reveal cancer in women with rare but benign breast condition

A study at Washington University School of Medicine in St. Louis showed that in women whose initial breast biopsies revealed certain rare, yet benign breast conditions, more extensive follow-up surgical biopsies found cancer up to 25 percent of the time. Most of the cancers were invasive, meaning the tumors had penetrated normal breast tissue and would require treatment.

Read more »

Keywords: surgical, biopsy, reveal, cancer, women, rare, benign, breast, condition

« Previous | Next »

Similar news on "Surgical biopsy may reveal cancer in women with rare but benign breast condition":

1. Breast MRI may help determine surgical management of women with newly diagnosed breast cancer
   05-21-2007 · EurekAlert!
   Among women who are newly diagnosed with breast cancer, magnetic resonance imaging (MRI) of the breast appears helpful in determining surgical treatment, according to a report in the May issue of Archives of Surgery, one of the JAMA/Archives journals.
   Similar news · Read more »
   
2. Women with breast cancer have less dermatitis when treated with IMRT
   10-28-2007 · EurekAlert!
   All women treated with radiation therapy for breast cancer are at risk of developing dermatitis -- a sometimes-painful skin condition caused by radiation as it makes its way through the skin to the tumor area and tissue within the breast. But researchers at Fox Chase Cancer Center say women being treated with intensity-modulated radiation therapy are less likely to have serious dermatitis.
   Similar news · Read more »
   
3. Herceptin does not increase heart failure in patients long term
   06-03-2007 · EurekAlert!
   Risk of congestive heart failure in women treated with trastuzumab and combination chemotherapy for early stage breast cancer did not increase over time according to a five-year follow up of National Surgical Adjuvant Breast and Bowel Project trial B-31 led by the University of Pittsburgh School of Medicine. Based on the findings, the research team developed a prediction model to help oncologists assess the risk of heart failure in individual breast cancer patients prior to treatment with Herceptin and chemotherapy.
   Similar news · Read more »
   
4. New study demonstrates efficacy of Pfizer's Aromasin for early breast cancer
   12-15-2006 · EurekAlert!
   New data from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-33 study, presented today at the San Antonio Breast Cancer Symposium, showed that postmenopausal women with hormone receptor-positive breast cancer who received Aromasin after five years of tamoxifen were 56 percent less likely to have a relapse of breast cancer than those who received placebo.
   Similar news · Read more »
   
5. Women with breast cancer do not get potentially life-saving information, survey reveals
   05-24-2007 · EurekAlert!
   New published data from a large pan-European survey indicate that the majority of postmenopausal women with early breast cancer taking post-surgical endocrine therapy are not involved in making key decisions about their treatment, nor are they given sufficient information to make informed treatment choices that could affect their long-term outcome.
   Similar news · Read more »
   
6. Increasing radiation dose shortens treatment time for women who choose breast sparing treatment
   05-29-2007 · EurekAlert!
   Radiation therapy after lumpectomy for early-stage breast cancer can be safely delivered in higher daily doses to greatly reduce treatment time. This conclusion of a new Fox Chase Cancer Center study is good news for women who might opt to have a mastectomy instead of a lumpectomy because of the time commitment needed for the usual six-week radiation course with the breast-sparing surgical option.
   Similar news · Read more »
   
7. Study finds patients with complex fibroadenomas can avoid surgery
   02-11-2008 · EurekAlert!
   Complex fibroadenomas have a low incidence of malignancy, so women with this condition can be more conservatively treated and avoid surgical biopsy, according to a new study by a team of researchers from the Hadassah-Hebrew University Medical Center in Jerusalem.
   Similar news · Read more »
   
8. Growth factors given with chemotherapy associated with increased risk of blood diseases
   02-06-2007 · EurekAlert!
   Women with breast cancer who receive compounds that stimulate white blood cell production to help their bodies better tolerate chemotherapy are at an increased risk of developing a type of leukemia or a condition called myelodysplastic syndrome, according to a new study in the February 7, Journal of the National Cancer Institute. The authors note that the absolute risk of the conditions is very small, but that risk should still be taken into consideration when making treatment decisions.
   Similar news · Read more »
   
9. Herceptin does not increase heart failure in patients long-term
   06-03-2007 · EurekAlert!
   Risk of congestive heart failure in women treated with trastuzumab and combination chemotherapy for early-stage breast cancer did not increase over time according to a five-year follow-up of National Surgical Adjuvant Breast and Bowel Project trial B-31 led by the University of Pittsburgh School of Medicine. Based on the findings, the research team developed a prediction model to help oncologists assess the risk of heart failure in individual breast cancer patients prior to treatment with Herceptin and chemotherapy.
   Similar news · Read more »
   
10. Chemotherapy may be culprit for fatigue in breast cancer survivors
    09-10-2007 · EurekAlert!
    A new study finds that, compared to healthy women, breast cancer survivors reported more days of fatigue and more severe fatigue symptoms.
    Similar news · Read more »